GlassScriptPhysician profile
Tina Schmidt
NPI 1316198385
$1,962.12
in general payments reported to CMS, 2019-2025
38 companies · $641 in 2025
The $641 reported for 2025 was more than what 81% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.94 · 2022: $132 · 2023: $479 · 2024: $616 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,624 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,624.08 |
| Education | $111.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $477.02 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $182.08 | 2021-2025 | Imfinzi, Enhertu, Calquence |
| Emd Serono, INC. | $127.58 | 2023-2024 | Bavencio |
| Daiichi Sankyo INC. | $88.84 | 2023-2025 | Enhertu, Injectafer |
| Glaxosmithkline, LLC. | $85.75 | 2021-2025 | Ojjaara |
| Celgene Corporation | $78.97 | 2023-2025 | Reblozyl |
| Incyte Corporation | $76.73 | 2023-2024 | Monjuvi, Pemazyre, Jakafi |
| Abbvie INC. | $55.62 | 2025 | |
| Astellas Pharma US INC | $50.97 | 2023-2025 | Xtandi, Padcev |
| Welch Allyn | $44.36 | 2021 | |
| Tempus Ai, INC | $43.65 | 2024 | |
| Sobi, INC | $42.73 | 2023 | |
| Lilly USA, LLC | $38.71 | 2023-2024 | Verzenio, Retevmo, Jaypirca |
| Amgen INC. | $35.48 | 2023 | Nplate, Xgeva, Vectibix |
| Pfizer INC. | $34.93 | 2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.